Clearly, we need more data in this area. Endometrial disease is another concern for HRT users. The relative risk increases by about 1 each year after 50. HRT also has been shown to decrease bone density loss among postmenopausal women, and preliminary studies have shown some evidence that HRT may protect against dementia, Alzheimer's disease, and loss of cognitive functioning. Available formulations, delivery systems, and dosing regimens for HRT have also changed in the past few years.
Physicians now have a much larger number of options to consider in individualizing therapy.
He described the initiation and management of HRT in the primary care setting and covered the benefits of the various treatment regimens. While it is an important therapy to prevent many major diseases that women get after menopause, we need to remember that here are alternatives such as diet, exercise, and other treatments like biophosphonates and lipid-lowering agents. FP Report is published by the AAFP News Department .